abstract |
Formula useful for the treatment of diseases mediated by the action of CCR3 [R 1 and R 2 independently have (C 1-6 ) alkyl, (C 1-6 ) alkoxy, halo (C 1-6 ) alkyl, halogen or 5 or 6 ring members, and (C 6-18 ) aryl or (C 6-18 ) aryl (C 1-6 ) substituted one or more times with a substituted or unsubstituted heterocyclyl having 1 to 4 heteroatoms selected from N, O, S Is alkyl)] Compound. |